Quick Answer
Century Therapeutics, Inc. reported Total Assets of $223.70 million for fiscal year 2025.
Century Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $223.70M | -36.7% |
| 2024 | $353.22M | -2.1% |
| 2023 | $360.69M | -25.9% |
| 2022 | $486.54M | +11.2% |
| 2021 | $437.38M | +309.6% |
| 2020 | $106.78M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $244.72M | -37.0% | -14.0% |
| June 30, 2025 | $284.69M | -31.6% | -9.8% |
| March 31, 2025 | $315.61M | -9.4% | -10.6% |
| December 31, 2024 | $353.22M | -2.1% | -9.1% |
| September 30, 2024 | $388.62M | -2.2% | -6.7% |
| June 30, 2024 | $416.45M | -0.2% | +19.5% |
| March 31, 2024 | $348.51M | -23.6% | -3.4% |
| December 31, 2023 | $360.69M | -25.9% | -9.3% |
- Century Therapeutics, Inc. showed a decrease of -36.7% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Century Therapeutics, Inc.’s total assets has grown by 109.5% (from $106.78 million to $223.70 million).
- The most recent figure is from Century Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: